Trilostane( Desopan | Modrefen | Vetoryl | WIN 24,540 )

Catalog No. M11506 CAS No. 13647-35-3

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Get Quotation Bulk Inquiry Add to Cart

Product Name

Trilostane
Note

Research use only, not for human use.
Brief Description

Trilostane is an inhibitor of 3 beta-hydroxysteroid dehydrogenase used in the treatment of Cushing's syndrome.
Description

Trilostane is an inhibitor of 3 beta-hydroxysteroid dehydrogenase used in the treatment of Cushing's syndrome.
In Vitro

——
In Vivo

Animal Model:Dogs with naturally-occurring pituitary-dependent hyperadrenocorticism (PDH)Dosage:5.3-50 mg/kg Administration:Oral administration; 5.3-50 mg/kg, once daily for 3 months Result:Effectively achieved endocrine control with safe effects and free of side-effects.
Synonyms

Desopan | Modrefen | Vetoryl | WIN 24,540
Pathway

Metabolic Enzyme/Protease
Target

Dehydrogenase
Recptor

3 β-hydroxysteroid dehydrogenase
Research Area

Endocrinology
Indication

——

CAS Number

13647-35-3
Formula Weight

329.43
Molecular Formula

C20H27NO3
Purity

>98% (HPLC)
Solubility

DMSO: 65 mg/mL (197.31 mM)
SMILES

N#CC1=C(O)[C@@]2([H])O[C@@]23[C@]([C@@]4([H])CC[C@@]5(C)[C@](CC[C@@H]5O)([H])[C@]4([H])CC3)(C)C1
Chemical Name

(1aR,4aR,4bS,6aS,7S,9aS,9bS,11aS)-2,7-dihydroxy-4a,6a-dimethyl-1a,4,4a,4b,5,6,6a,7,8,9,9a,9b,10,11-tetradecahydrocyclopenta[7,8]phenanthro[1,10a-b]oxirene-3-carbonitrile.

1.Puddefoot JR, et al. Expert Opin PharmacOthers. 2006 Dec;7(17):2413-9.

Calculator

molnova catalog